Alliancebernstein L.P. grew its stake in shares of Ignyta Inc (NASDAQ:RXDX) by 1,414.3% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 1,746,002 shares of the biopharmaceutical company’s stock after buying an additional 1,630,702 shares during the period. Alliancebernstein L.P. owned approximately 2.58% of Ignyta worth $46,618,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Trexquant Investment LP acquired a new position in shares of Ignyta during the third quarter valued at about $152,000. LMR Partners LLP acquired a new position in shares of Ignyta during the third quarter valued at about $169,000. TD Asset Management Inc. raised its position in shares of Ignyta by 26.0% during the third quarter. TD Asset Management Inc. now owns 16,600 shares of the biopharmaceutical company’s stock valued at $205,000 after buying an additional 3,425 shares during the last quarter. Amalgamated Bank acquired a new position in shares of Ignyta during the fourth quarter valued at about $213,000. Finally, State Board of Administration of Florida Retirement System acquired a new position in shares of Ignyta during the third quarter valued at about $224,000. 72.28% of the stock is owned by institutional investors and hedge funds.
Ignyta Inc (RXDX) opened at $26.98 on Wednesday. Ignyta Inc has a 52-week low of $5.80 and a 52-week high of $27.10. The company has a debt-to-equity ratio of 0.34, a current ratio of 6.07 and a quick ratio of 6.07. The stock has a market cap of $1,790.00, a PE ratio of -9.94 and a beta of 184.87.
Ignyta, Inc is a biotechnology company. The Company is focused on precision medicine in oncology. The Company is pursuing an integrated therapeutic (Rx) and companion diagnostic (Dx) strategy for treating cancer patients. The Company’s pipeline includes various compounds, such as entrectinib, RXDX-105, taladegib and RXDX-106.
Want to see what other hedge funds are holding RXDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ignyta Inc (NASDAQ:RXDX).
Receive News & Ratings for Ignyta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ignyta and related companies with MarketBeat.com's FREE daily email newsletter.